Exposures of Phenylacetic Acid and Phenylacetylglutamine Across Different Subpopulations and Correlation with Adverse Events.

Wang, Xiaofeng; Tseng, Jack; Mak, Carmen; Poola, Nagaraju; Vilchez, Regis A

Wang, Xiaofeng; Tseng, Jack; Mak, Carmen; Poola, Nagaraju; Vilchez, Regis A.

Afiliação

Wang X; Clinical Pharmacology and Pharmacometrics, Mallinckrodt Pharmaceuticals, Hampton, NJ, USA.
Tseng J; Clinical Development, Mallinckrodt Pharmaceuticals, Hampton, NJ, 08827, USA.
Mak C; Clinical Development, Mallinckrodt Pharmaceuticals, Hampton, NJ, 08827, USA.
Poola N; Clinical Pharmacology and Pharmacometrics, Mallinckrodt Pharmaceuticals, Hampton, NJ, USA.
Vilchez RA; Clinical Development, Mallinckrodt Pharmaceuticals, Hampton, NJ, 08827, USA. regis.vilchez@mnk.com.

Clin Pharmacokinet ; 60(12): 1557-1567, 2021 12.

Article em En | MEDLINE | ID: mdl-34125423

Assuntos

Amônia; Fenilacetatos; Glutamina/análogos & derivados; Humanos; Fenilacetatos/efeitos adversos

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fenilacetatos / Amônia Tipo de estudo: Prognostic_studies Limite: Humans Idioma: En Revista: Clin Pharmacokinet Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google